O'Brien Wealth Partners’s Sanofi SNY Stock Holding History

O'Brien Wealth Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-80	Closed	-$4K	–	174
2018 Q3	$4K	Buy	+80	New	+$3.42K	﹤0.01%	176

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

O'Brien Wealth Partners's SNY Position: Q4 2018 in Review

O'Brien Wealth Partners sold out of Sanofi (SNY) in Q4 2018, closing a stake of 80 shares — an estimated $4K sold.

O'Brien Wealth Partners first reported a position in SNY in Q3 2018 and held it in 1 quarter. The position peaked at $4K in Q3 2018. 501 funds tracked by Wall St. Rank hold SNY as of Q4 2018.

O'Brien Wealth Partners reported no remaining Sanofi position as of Q4 2018 after selling out during the quarter.
O'Brien Wealth Partners sold 80 Sanofi shares in Q4 2018, an estimated $4K.
O'Brien Wealth Partners first reported a position in Sanofi in Q3 2018 and held it in 1 quarter.
O'Brien Wealth Partners's Sanofi position peaked at $4K in Q3 2018.
501 funds tracked by Wall St. Rank held Sanofi as of Q4 2018.

Based on O'Brien Wealth Partners's 13F filing for Q4 2018, filed 17 Jan 2019.